[REVISION HISTORY]
Evotec leadership restructuring
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-09-29 19:53 UTC → 2026-09-30 15:13 UTC ·
added
removed
Evotec has undergone a series of leadership transitions following a period of significant corporate growth. Initially, the company announced a management restructuring that included the promotion of two internal candidates to new executive roles. By late September, the company confirmed that Chief Scientific Officer Dr. Cord Dohrmann will step down on September 30, 2026. The departure was described as being by “mutual agreement.” Dr. Dohrmann, who joined the company in 2010, was noted for his role in developing iPSC-based technologies and Omics capacities. Evotec is currently searching for a successor. As of late September 2026, Evotec’s stock has shown signs of stability despite the upcoming departure of Dr. Dohrmann after 16 years with the firm.
Versions
- 2026-09-30 15:13 UTC Evotec leadership restructuring
- 2026-09-29 19:53 UTC Evotec leadership restructuring
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.